Sidney Wolfe News
-
Immigrants to the U.S. contributed $115.2 billion more to the Medicare Trust Fund during the past decade than they withdrew, casting doubt on criticism they overburden the health plan, Harvard University researchers said.
-
With a record 720 dissenting opinions to his credit, former Supreme Court Justice John Paul Stevens joked that he should be given “a lifetime failure award.”
-
Catherine DeAngelis, the first female editor-in-chief of the Journal of the American Medical Association , is stepping down after a decade of raising the standards for fact checking of the pharmaceutical industry.
-
Drug companies and medical-device makers would be forced to publicly disclose any money paid to doctors under new U.S. regulations designed to make patients aware of conflicts of interest that may affect their health.
-
Higher doses of an Alzheimer’s drug sold by Eisai Co. and Pfizer Inc. endanger patients and don’t enhance the treatment’s effectiveness, according to a consumer group that wants the regimen banned.
-
Darvon, a 53-year-old pain pill, will be pulled from the U.S. market after a study found potentially fatal heart risks in healthy people who take the medicine at the recommended dose.
-
Europe’s drug regulator will make thousands of pages of clinical trial reports public next week after pressure from drug-safety activists because of suicide risks linked to Sanofi-Aventis SA ’s failed diet pill Acomplia.
-
The Food and Drug Administration is weighing whether to let consumers buy medicines for some chronic conditions without a prescription while speeding approvals of drugs for infection, Alzheimer’s disease and rare conditions.
-
U.S. regulators won’t re-examine safety data from fen-phen, the recalled diet drug tied to heart damage, as they review a new generation of weight-loss pills led by Vivus Inc. ’s Qnexa that use some of the same ingredients.
-
The American Red Cross, the biggest U.S. supplier of donated blood, failed to correct violations of blood-safety rules, raising the risk that ill-suited blood will be used in transfusions, U.S. regulators said.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page